OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex molecules. Improving these processes involves modifying various parameters, including cell line development, media ingredients, and bioreactor settings. A key goal is to amplify antibody yield while reducing production financial